Close
Nordic 9Nordic 9

Kupando (private company)

Germany kupando.com
See something wrong or missing? Let us know
Offices:Berlin
Industry:Health servicesManufacturingPharma
Business model:B2B

Kupando is a biopharmaceutical company frm Germany developing a TLR 4/7 agonist that stimulates innate immunity for use in oncology and infectious diseases.

Investors: we tracked 5 investors

You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

values in USD

Investments 12.45M

You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

Companies with similar profile to Kupando

Name Criteria
United Kingdom Beckley Psytech
70%
  • Similar verticals: Health services, Manufacturing, Pharma
  • Similar business models: B2B
  • At least one vc investor: found 3
  • At least one other investor: found 2
  • Total raised in a similar range: 10M+ USD
Denmark Cytoki Pharma
70%
  • Similar verticals: Health services, Manufacturing, Pharma
  • Similar business models: B2B
  • At least one vc investor: found 3
  • At least one other investor: found 1
  • Total raised in a similar range: 10M+ USD
Germany Abalos Therapeutics
70%
  • Similar verticals: Health services, Manufacturing, Pharma
  • Similar business models: B2B
  • At least one vc investor: found 3
  • At least one other investor: found 2
  • Total raised in a similar range: 10M+ USD
Germany Emergence Therapeutics
70%
  • Similar verticals: Health services, Manufacturing, Pharma
  • Similar business models: B2B
  • At least one vc investor: found 3
  • At least one other investor: found 2
  • Total raised in a similar range: 10M+ USD
Belgium Precirix
70%
  • Similar verticals: Health services, Manufacturing, Pharma
  • Similar business models: B2B
  • At least one vc investor: found 3
  • At least one other investor: found 2
  • Total raised in a similar range: 10M+ USD
Italy Kither Biotech
70%
  • Similar verticals: Health services, Manufacturing, Pharma
  • Similar business models: B2B
  • At least one vc investor: found 3
  • At least one other investor: found 2
  • Total raised in a similar range: 10M+ USD
United Kingdom OMass Therapeutics
70%
  • Similar verticals: Health services, Manufacturing, Pharma
  • Similar business models: B2B
  • At least one vc investor: found 3
  • At least one other investor: found 1
  • Total raised in a similar range: 10M+ USD
France Qubit Pharmaceuticals
67%
  • Similar verticals: Health services, Manufacturing, Pharma
  • Similar business models: B2B
  • At least one vc investor: found 2
  • At least one other investor: found 1
  • Total raised in a similar range: 10M+ USD
Netherlands InnoSIGN
65%
  • Similar verticals: Health services, Manufacturing, Pharma
  • Similar business models: B2B
  • At least one vc investor: found 3
  • At least one other investor: found 1
France SafeHeal
63%
  • Similar verticals: Health services, Manufacturing, Pharma
  • Similar business models: B2B
  • At least one vc investor: found 1
  • At least one other investor: found 1
  • Total raised in a similar range: 10M+ USD
Top